Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001567619-21-013528
Filing Date
2021-07-15
Accepted
2021-07-15 20:14:26
Documents
2
Period of Report
2021-07-05

Document Format Files

Seq Description Document Type Size
1 FORM 3 doc1.html 3  
1 FORM 3 doc1.xml 3 1749
2 poa_kundu.htm EX-24 10048
  Complete submission text file 0001567619-21-013528.txt   13141
Mailing Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705
Business Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705 240-399-4900
NextCure, Inc. (Issuer) CIK: 0001661059 (see all company filings)

EIN.: 475231247 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 9000 VIRGINIA MANOR ROAD SUITE 200 BELTSVILLE MD 20705
Business Address
Kundu Sourav (Reporting) CIK: 0001872985 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38905 | Film No.: 211093883